Approvals/TGA/STEQEYMA ustekinumab 130 mg/26 mL concentrate for solution for infusion vial

Approved

STANDARD

STEQEYMA ustekinumab 130 mg/26 mL concentrate for solution for infusion vial

Celltrion Healthcare Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 7b78e8461c91f816
Product Name: STEQEYMA ustekinumab 130 mg/26 mL concentrate for solution for infusion vial
Artg Id: 420571
Artg Name: STEQEYMA ustekinumab 130 mg/26 mL concentrate for solution for infusion vial
Sponsor: Celltrion Healthcare Australia Pty Ltd
Company Detail Path: /organization/celltrion-healthcare-australia-pty-ltd
Artg Date: 2024-09-11
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Product Information: https://medical-cdn.nocode.com/drug_tga/25405731d7c41ee504824da14769b99c.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

7b78e8461c91f816

Type

Standard